阿弗利塞普特与贝瓦西祖马布作为与年龄相关的黄斑退化症的第一线治疗
Mădălina-Casiana Palfi Salavat1, Edward Paul Șeclăman2, Andreea-Alexandra Mușat3
1Department of Ophthalmology, "Victor Babeş" University of Medicine and Pharmacy, 300041 Timisoara.
Current health sciences journal
|April 1, 2024
概括
内阿弗利塞普特和贝瓦西祖马布注射有效地治疗与年龄相关的新血管性黄斑变性 (AMD),改善视力敏度. 在这项研究中,阿弗利伯塞普特与贝瓦齐祖马布相比,显示出更快,更持久的效果.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 与年龄相关的黄斑变性 (AMD) 是60岁以上人群中视力丧失的主要原因.
- 在近距离和远距离任务中,AMD特别影响中央视力,而不是外围视力.
- 神经血管性AMD是一种渐进的疾病,可以导致不可逆转的中心失明.
研究的目的:
- 为了评估和比较眼睛和全身效应的内阿弗利贝塞普与贝瓦西祖马布对新血管AMD治疗.
- 评估这些抗VEGF药物的有效性,当在可比剂量和治疗方案中使用时.
主要方法:
- 一个回顾性,单中心研究,涉及18名新血管AMD治疗先患者.
- 患者被随机分配给通过静脉内注射 (每组9名患者) 接受aflibercept或bevacizumab.
- 治疗包括每月3次注射,1,3个月和9个月后进行随访,评估视力敏度,眼内压力和OCT成像.
主要成果:
- 所有18名患者在治疗后都经历了视力敏度的改善.
- 与贝瓦西祖马布相比,Aflibercept对视力敏度产生了更快速,更长时间的效果.
- 在两组治疗中都观察到视网膜缺血区域,在aflibercept治疗中出现较早.
结论:
- 内抗VEGF治疗,包括aflibercept和bevacizumab,可以显著改善新血管AMD中的视力敏度.
- 阿弗利伯塞普可能比贝瓦西祖马布提供更快的发病和更持久的视觉益处.
- 通过OCT早期检测和及时的视内治疗对于减缓与AMD相关的中央视力损失的进展至关重要.
更多相关视频
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
2.0K
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
1.1K
相关概念视频
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...